Pre-eclampsia and eclampsia: An update on the pharmacological treatment applied in Portugal

GM Peres, M Mariana, E Cairrão - Journal of cardiovascular development …, 2018 - mdpi.com
Pre-eclampsia and eclampsia are two hypertensive disorders of pregnancy, considered
major causes of maternal and perinatal death worldwide. Pre-eclampsia is a multisystemic …

[PDF][PDF] Evaluation and management of premature rupture of membranes: a review article

A Garg, A Jaiswal - Cureus, 2023 - cureus.com
Premature rupture of membranes (PROM), now also referred to as" pre-labour rupture of
membranes," is the rupture of gestational membranes after 37 weeks but before the process …

[HTML][HTML] Fetal neuroprotection by magnesium sulfate: from translational research to clinical application

C Chollat, L Sentilhes, S Marret - Frontiers in neurology, 2018 - frontiersin.org
Despite improvements in perinatal care, preterm birth still occurs regularly and the
associated brain injury and adverse neurological outcomes remain a persistent challenge …

Magnesium sulfate and fetal neuroprotection: overview of clinical evidence

C Chollat, S Marret - Neural regeneration research, 2018 - journals.lww.com
Antenatal administration of magnesium sulfate is an important part of the neuroprotective
strategy for preterm infants. Strong evidence from five randomized controlled trials and five …

MAGnesium sulphate for fetal neuroprotection to prevent Cerebral Palsy (MAG-CP)—implementation of a national guideline in Canada

DA De Silva, AR Synnes, P von Dadelszen, T Lee… - Implementation …, 2018 - Springer
Background Evidence supports magnesium sulphate (MgSO4) for women at risk of imminent
birth at< 32–34 weeks to reduce the likelihood of cerebral palsy in the child. MAGnesium …

Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study

HT Wolf, L Huusom, T Weber, A Piedvache… - BMJ open, 2017 - bmjopen.bmj.com
Objectives The use of magnesium sulfate (MgSO4) in European obstetric units is unknown.
We aimed to describe reported policies and actual use of MgSO4 in women delivering …

Evaluation of standard and enhanced quality improvement methods to increase the uptake of magnesium sulphate in pre-term deliveries for the prevention of …

HB Edwards, MT Redaniel, C Sillero-Rejon… - medRxiv, 2022 - medrxiv.org
Objective To investigate the impact of an enhanced QI support programme (ESP) in further
improving the magnesium sulphate (MgSO4) uptake compared to the National PReCePT …

Antenatal Magnesium Sulfate and adverse gastrointestinal outcomes in Preterm infants—a systematic review and meta-analysis

A Prasath, N Aronoff, P Chandrasekharan… - Journal of …, 2023 - nature.com
Introduction To evaluate the effect of antenatal magnesium sulfate (MgSO4) on mortality and
morbidity outcomes related to the gastrointestinal system (GI) in preterm infants. Methods …

Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey

C Chollat, L Le Doussal, G de La Villéon… - BMC Pregnancy and …, 2017 - Springer
Abstract Background Magnesium sulphate (MgSO 4) is the only treatment approved for fetal
neuroprotection. No information on its use is available in the absence of a national registry …

Quality improvement interventions to increase the uptake of magnesium sulphate in preterm deliveries for the prevention of cerebral palsy (PReCePT study): a cluster …

HB Edwards, MT Redaniel… - … Journal of Obstetrics …, 2024 - Wiley Online Library
Objective To compare two quality improvement (QI) interventions to improve antenatal
magnesium sulphate (MgSO4) uptake in preterm births for the prevention of cerebral palsy …